Rchr
J-GLOBAL ID：201901020077100250
Update date: Feb. 01, 2024
Shinsuke Hirabayashi
Shinsuke Hirabayashi
Affiliation and department：
Research field (1)：
Hematology and oncology
Research theme for competitive and other funds (3)：
- 2021 - 2024 小児・AYA世代におけるMDSの発生機序と治療戦略の解明
- 2018 - 2021 本邦の小児~若年成人骨髄異形成症候群における先天性素因と臨床像の解明
- 2016 - 2019 Research for mechanism of hematological malignancies in rare syndrome in children
Papers (57)：
-
Yohei Nishiyama, Kazuyoshi Mizuki, Akihiro Hoshino, Shinsuke Hirabayashi, Tatsuya Magara, Miho Ashiarai, Satoshi Miyamoto, Rintaro Ono, Shuhei Takahashi, Yosuke Hosoya, et al. Hematopoietic cell transplantation for hematological malignancies in Bloom syndrome. Pediatric blood & cancer. 2023. e30655
-
Hiroyuki Kimura, Masahiro Onozawa, Shota Yoshida, Naoki Miyashita, Shota Yokoyama, Toshihiro Matsukawa, Shinsuke Hirabayashi, Hideki Goto, Tomoyuki Endo, Satoshi Oguri, et al. Dominant-negative type of IKZF1 deletion showed a favorable prognosis in adult B-cell acute lymphoblastic leukemia. Annals of hematology. 2023
-
Naoki Miyashita, Masahiro Onozawa, Shota Yoshida, Hiroyuki Kimura, Shogo Takahashi, Shota Yokoyama, Toshihiro Matsukawa, Shinsuke Hirabayashi, Shinichi Fujisawa, Akio Mori, et al. Prognostic impact of FLT3-ITD, NPM1 mutation and CEBPA bZIP domain mutation in cytogenetically normal acute myeloid leukemia: a Hokkaido Leukemia Net study. International journal of hematology. 2023. 118. 1. 36-46
-
Jimei Zhao, Masahiro Ueki, Saori Sawai, Minako Sugiyama, Yukayo Terashita, Shinsuke Hirabayashi, Yuko Cho, Ryoji Kobayashi, Yoichi Tanaka, Atsushi Manabe. The heterozygous NUDT15 variant is not associated with the severity of 6-mercaptopurine-related side effects in early intensification therapy for childhood acute lymphoblastic leukemia. EJC Paediatric Oncology. 2023. 1. 100006-100006
-
Kentaro Ohki, Ellie R Butler, Nobutaka Kiyokawa, Shinsuke Hirabayashi, Anke K Bergmann, Anja Möricke, Judith M Boer, Hélène Cavé, Giovanni Cazzaniga, Allen Eng Juh Yeoh, et al. Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group. Leukemia. 2022
ｍore...
MISC (33)：
-
長祐子, 澤井彩織, 原和也, 寺下友佳代, 杉山未奈子, 平林真介, 真部淳, 杉山拓, 方波見謙一, 浜崎和朗. How should we manage multiple intracerebral hemorrhage and brain death in a patient with T-ALL?. 日本小児科学会雑誌. 2022. 126. 2
-
Hirabayashi Shinsuke, Yamamoto Shunsuke, Yamamoto Kaoru, Yamamoto Kazuki, Aiga Saori, Daida Atsuro, Ono Rintaro, Ashiarai Miho, Nishimura Akira, Hosoya Yosuke, et al. Dasatinib-Combined Less Intensive Chemotherapy for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Down Syndrome. PEDIATRIC BLOOD & CANCER. 2018. 65. S97
-
Ashiarai Miho, Umehara Naoki, Kuroko Yurika, Yamamoto Kaoru, Yamamoto Shunsuke, Ono Rintaro, Hirabayashi Shinsuke, Hosoya Yosuke, Hasegawa Daisuke, Manabe Atsushi. Successful Inhaled Nitric Oxide Therapy for Severe Acute Respiratory Failure Due to Alveolar Hemorrhage During Induction Phase in AML M5. PEDIATRIC BLOOD & CANCER. 2018. 65. S55-S56
-
宮本智史, 宮本智史, 木村俊介, 細谷要介, 長谷川大輔, 石田悠志, 代田惇朗, 松井俊大, 吉本優里, 平林真介, et al. Transplantation-associated thrombotic microangiopathy confirmed by renal biopsy. 臨床血液. 2018. 59. 4
-
Nobutaka Kiyokawa, Takashi Fukushima, Kentaro Ohki, Motohiro Kato, Takeshi Ishibashi, Ai Yoshimi, Yuya Saito, Takahiro Aoki, Kazuki Terada, Osamu Tomita, et al. Close Correlation Between Immunophenotype and Genetic Abnormalities in Childhood Acute Lymphoblastic Leukemia: Results from TCCSG Study L04-16. PEDIATRIC BLOOD & CANCER. 2017. 64. S17-S17
ｍore...
Education (2)：
- 2014 - 2018 東邦大学大学院臨床腫瘍学
- 1998 - 2004 山梨医科大学医学部
Professional career (2)：
- 医学 学士 (山梨医科大学)
- 医学 博士 (東邦大学)
Work history (4)：
- 2019/08 - 現在 北海道大学小児科
- 2013/11 - 2019/07 聖路加国際病院小児科
- 2009/11 - 2013/10 ドイツ、フライブルク大学小児病院血液腫瘍科
- 2004/04 - 2009/10 聖路加国際病院小児科
Association Membership(s) (4)：
日本造血細胞移植学会
, 日本小児血液・がん学会
, 日本血液学会
, 日本小児科学会
